We are live on ! Find out more
RPTX

Repare Therapeutics
RPTX

Delisted

RPTX was delisted on the 27th of January, 2026.

Back to rankings

61 hedge funds and large institutions have $828M invested in Repare Therapeutics in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 19 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more call options, than puts

Call options by funds: $518K | Put options by funds: $268K

1.3% more ownership

Funds ownership: 70.44% → 71.73% (+1.3%)

4% more capital invested

Capital invested by funds: $797M → $828M (+$30.8M)

6% less funds holding

Funds holding: 65 → 61 (-4)

11% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 19

29% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 14

33% less funds holding in top 10

Funds holding in top 10: 6 → 4 (-2)

Holders
61
Holders Change
-4
Holders Change %
-6.15%
% of All Funds
1.06%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.07%
New
10
Increased
17
Reduced
19
Closed
14
Calls
$518K
Puts
$268K
Net Calls
+$250K
Net Calls Change
+$250K

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$36.7M
2
AIM
ARK Investment Management
Florida
+$21.9M
3
GPP
Great Point Partners
Connecticut
+$14.3M
4
SAM
Sectoral Asset Management
Quebec, Canada
+$13.2M
5
Citadel Advisors
Citadel Advisors
Florida
+$6.04M

Top Sellers

Rank Fund Capital Flow
1
LGM
Logos Global Management
California
-$18.7M
2
MB
MPM BioImpact
Massachusetts
-$12.9M
3
RCM
RA Capital Management
Massachusetts
-$12.6M
4
MAM
MPM Asset Management
Massachusetts
-$10.9M
5
JP Morgan Chase
JP Morgan Chase
New York
-$5.98M
Name Holding Trade Value Shares
Change 		Change in
Stake
TD Asset Management
26
TD Asset Management
Ontario, Canada
$1.5M +$1.47M +44,900 New
Vanguard Group
27
Vanguard Group
Pennsylvania
$1.05M -$4.39K -134 -0.4%
Citigroup
28
Citigroup
New York
$869K +$887K +27,086 +3,394%
HTC
29
Hershey Trust Company
Pennsylvania
$771K -$158K -4,831 -16%
Millennium Management
30
Millennium Management
New York
$704K +$740K +22,585 New
Geode Capital Management
31
Geode Capital Management
Massachusetts
$667K – – –
Swiss National Bank
32
Swiss National Bank
Switzerland
$649K – – –
Renaissance Technologies
33
Renaissance Technologies
New York
$636K +$668K +20,400 New
Ensign Peak Advisors
34
Ensign Peak Advisors
Utah
$605K – – –
Northern Trust
35
Northern Trust
Illinois
$487K +$511K +15,597 New
State Street
36
State Street
Massachusetts
$470K +$494K +15,083 New
HP
37
Harbourvest Partners
Massachusetts
$460K +$80.9K +2,471 +20%
DekaBank Deutsche Girozentrale
38
DekaBank Deutsche Girozentrale
Germany
$424K – – –
HF
39
HRT Financial
New York
$376K +$396K +12,083 New
SFI
40
Susquehanna Fundamental Investments
Pennsylvania
$296K – – –
Mitsubishi UFJ Asset Management
41
Mitsubishi UFJ Asset Management
Japan
$272K +$286K +8,736 New
SCM
42
Soleus Capital Management
Connecticut
$228K -$4.13M -126,024 -95%
VEA
43
Virtus ETF Advisers
New York
$213K -$25.7K -784 -10%
ProShare Advisors
44
ProShare Advisors
Maryland
$207K +$218K +6,649 New
CS
45
Credit Suisse
Switzerland
$201K -$67.5K -2,062 -24%
UBS Group
46
UBS Group
Switzerland
$179K +$142K +4,332 +306%
Bank of America
47
Bank of America
North Carolina
$151K -$506K -15,451 -76%
TRCT
48
Tower Research Capital (TRC)
New York
$110K +$10.2K +311 +10%
GGHC
49
Gilder Gagnon Howe & Co
New York
$101K – – –
JP Morgan Chase
50
JP Morgan Chase
New York
$56K -$5.98M -182,688 -99%
1
2
3

RPTX Hedge Fund Activity: Q2 2021 in Review

61 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q2 2021, worth a combined $828M — up 3.9% from $797M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of RPTX and 10 opened new positions — a net loss of 4 holders — while 19 trimmed existing stakes and 17 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $36.7M. The largest seller was Logos Global Management, cutting an estimated $18.7M.

  • 61 institutional investors held Repare Therapeutics (RPTX) as of Q2 2021, down from 65 in Q1 2021.
  • Funds reported $828M of Repare Therapeutics stock for Q2 2021, up 3.9% quarter-over-quarter.
  • 10 funds opened new Repare Therapeutics positions in Q2 2021 and 14 closed out, a net change of -4 holders.
  • The largest Repare Therapeutics buyer in Q2 2021 was T. Rowe Price Associates, an estimated $36.7M added.
  • The largest Repare Therapeutics seller in Q2 2021 was Logos Global Management, an estimated $18.7M sold.

Based on aggregated 13F filings for Q2 2021.